Loading...
Home 2017-11-16T15:35:26+00:00

BIOMIMETIC GLUCOSE BINDING MOLECULES

Our mission is to help people with diabetes to live more normal and longer lives. We are using our proprietary Biomimetic Glucose Binding Molecules (GBM) to help enable our partners to make the next generation of Continuous Glucose Monitors (CGM) and Glucose Responsive Insulins (GRI).

SELECTIVE MONITORING

Our GBMs offer unparalleled selectivity towards glucose and function in even the most complex biological mixtures.

STABLE & VERSATILE

Our GBMs are extremely robust with a multi-year operational potential.

SCALABLE PLATFORM

Ziylo’s GBMs are produced by a streamlined, scalable synthesis and are readily derivatised for bioconjugation and chemical synthesis.

ABOUT ZIYLO

Ziylo is a supramolecular chemistry company that has developed a third ‘biomimetic’ class of glucose binding molecule (GBM). These molecules are at the core of medical devices such as Continuous Glucose Monitors (CGM) and therapeutics such as Glucose Responsive Insulins (GRI). Our platform technology is based on over 20 years of cutting-edge research pioneered by Professor Anthony Davis’ group at the University of Bristol. Inspired by nature’s carbohydrate-binding molecules (lectins), Professor Davis has become a leader in the field of ‘Synthetic Lectins’ – biomimetic molecules that are capable of binding carbohydrates like glucose in water. This award-winning chemistry has been published in Science and Nature Chemistry and has laid the foundation for the discovery our Biomimetic GBM platform.

New vaccines, drug targeting systems for heart tissue repair, and gene therapy vectors.

Read our write up from the @BrisSynBio Life Science Showcase at Unit DX - https://t.co/zc6Kq61mYP

New vaccines, drug targeting systems for heart tissue repair, and gene therapy vectors. 

Read our write up from the @BrisSynBio Life Science Showcase at Unit DX - https://t.co/zc6Kq61mYP

The Unit DX Newsletter #6 is online now. Includes an announcement on our equipment partnership with @TeledyneIsco, and a write-up from the @BrisSynBio Life Science Showcase.

#synbio #news #HPLC #science

Read and subscribe at https://t.co/7IMZ0lmgic

The Unit DX Newsletter #6 is online now. Includes an announcement on our equipment partnership with @TeledyneIsco, and a write-up from the @BrisSynBio Life Science Showcase. 

#synbio #news #HPLC #science 

Read and subscribe at https://t.co/7IMZ0lmgic

With over 1,500 companies helped and £1.25 bn raised in investment, we’re the global no. 1 #university #business incubator. Apply to become a member today: https://t.co/0ds4o2zDrN

With over 1,500 companies helped and £1.25 bn raised in investment, we’re the global no. 1 #university #business incubator. Apply to become a member today: https://t.co/0ds4o2zDrN

VWV's specialist #Technology team have committed to provide legal support to @Unit_DX Central Bristol's first scientific innovation centre. https://t.co/qmaEJTT6qT

VWV's specialist #Technology team have committed to provide legal support to @Unit_DX Central Bristol's first scientific innovation centre. https://t.co/qmaEJTT6qT
Load More...